AOD-9604
Anti-Obesity Drug-9604
A fragment of HGH (177-191) specifically designed for fat loss without affecting blood sugar or growth. One of the few peptides with human clinical trials for weight loss.
Typical Cost
$50-100/vial (5mg)
Status
Research
Peptide Profile
AOD-9604
Mechanism of Action
Mimics the lipolytic effect of HGH without the anabolic or diabetogenic effects. Stimulates lipolysis and inhibits lipogenesis in adipocytes.
Common Dosages
subcutaneous
300-600mcg
Daily · 12-16 weeks
Benefits
Targeted fat loss
No blood sugar effects
No IGF-1 elevation
No organ growth
Well-tolerated
Side Effects
Limited human data
Injection site reactions
Modest effect size
Key Research
AOD-9604 obesity trial
Modest weight loss in Phase IIb trial, well-tolerated
AOD-9604 safety
No adverse metabolic effects or growth hormone axis disruption
Regulatory Status
Completed Phase IIb trials for obesity. Not FDA-approved. Available as research chemical.
Contraindications
- ⚠Pregnancy/breastfeeding
- ⚠Active cancer
GLP-1 users achieve superior fat loss through GLP-1 medications. SeraVia Energy+ Boost supports metabolic health.
Learn More →Find peptide providers
Search 18,000+ clinics offering peptide therapy alongside GLP-1 medications.
Search Providers →Disclaimer: This information is for educational and research purposes only. Peptides described here may not be FDA-approved for human use. Always consult a qualified healthcare provider before using any peptide product. GLP1Search does not sell peptides.